The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conditional Placing

12 Mar 2020 16:27

RNS Number : 9828F
Asimilar Group PLC
12 March 2020
 

12 March 2020

Asimilar Group plc

("Asimilar" or the "Company")

Conditional placing to raise £7.5 million

Asimilar Group plc, the AIM quoted investing company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), announces that on 11 March 2020 it entered into a conditional placing ("Placing") to raise £7.5 million through the issue of 12,500,000 new Ordinary Shares at a price of 60 pence per share ("Placing Shares").

Warrants over 12,500,000 new Ordinary shares will be issued pursuant to the Placing. Each Placing Share will have a warrant attached to subscribe for one new Ordinary Share at a price of 130 pence, exercisable for two years from the date of admission to trading on AIM on completion of the Proposals as set out below ("Placing Warrants").

The Placing, which was significantly oversubscribed, is conditional, inter alia, on the re-admission of the Company's share capital to trading on AIM ("Admission") and has been undertaken to assist the Company to comply with its obligations under AIM Rule 8.

Admission would be by way of a reverse takeover transaction, details of which were set out in the announcement made by the Company on 4 March 2020. As stated in that announcement, the Company intends to publish an Admission Document and to convene a general meeting seeking shareholder approval to acquire new shares representing a circa 9.3% equity interest in Sentiance NV ("Sentiance"), a leading player in artificial intelligence ("AI"), machine learning and contextual behavioural data science for a consideration of €7.5 million, with options to acquire further existing and new shares in Sentiance (together the "Proposals").

In addition to the Placing Warrants, the Company has also conditionally agreed to issue warrants over 3,500,000 new Ordinary Shares in the Company on completion of the Placing to Chris Akers in relation to the Placing ("Introducer Warrants"). The Introducer Warrants will have an exercise price of 60 pence per Ordinary Share and can be exercised at any time until 31 December 2020.

The Placing is conditional, inter alia, on:

(a) the Company publishing an Admission Document for re-admission to trading on AIM;

(b) the Proposals being approved by shareholders at a general meeting of the Company;

(c) there being no material change in the circumstances and/or prospects of Sentiance prior to completion of the initial €7.5 million equity investment by Asimilar (as described in the RNS of 4 March 2020), as determined by Asimilar;

(d) Asimilar completing its initial €7.5 million equity investment in Sentiance; and

(e) the Company's enlarged share capital being admitted to trading on AIM.

In addition, Asimilar has reserved the right to renegotiate the terms of the Placing in the event of a change of control of Sentiance on or before Admission.

The suspension in trading in Asimilar's shares will be lifted on the publication of an Admission Document, which will include details of the proposed transaction, or in the event that that discussions between Asimilar and Sentiance terminate.

As part of the Placing, Nigel Wray, who is a substantial shareholder in the Company, has subscribed for 291,667 Ordinary Shares. Nigel Wray's participation in the Placing is considered to be a related party transaction under the AIM Rules for Companies. The Directors, having consulted with the Company's Nominated Adviser, consider that the terms of the participation of Mr Wray in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Further Information on Sentiance

Sentiance is a Belgian private company headquartered in Antwerp which is in the business of developing artificial intelligence software, machine learning and contextual behavioural data science.

Sentiance has developed proprietary software technology which can be embedded in any mobile application on any connected device which collects and analyses low level IoT sensor data in real time to produce behavioural insights about user location, transport mode and base level activities, detecting and predicting personal context based on the user's current situation and historical patterns and aggregating user patterns, routines and affinities into behavioural segments and profiles. These insights enable companies to understand how customers go through their everyday lives, discover and anticipate key moments for consumers, and adapt their engagement to real-world behaviour and real-time context. Sentiance' contextual intelligence enables solutions for lifestyle based insurance, contextual marketing and commerce, smart mobility, connected health, smart city and connected car. Sentiance's ultimate goal is to provide technology to improve people's lives.

Sentiance has recently closed a number of high profile client contracts with both global industry leaders and emerging challengers, across its core solution verticals: smart mobility, user-based insurance, connected car, personalised wellbeing services and consumer loyalty programs. With a growing roster of global clients and a validated and advanced qualified pipeline of new business opportunities across the globe, the Board believes that Sentiance is poised for significant growth.

According to the unaudited, unconsolidated accounts prepared in accordance with Belgian GAAP for the year ended 31 December 2018, the most recent financial year for which Sentiance has published accounts, Sentiance is a holding company with five subsidiary companies which incurred a loss in the year ended 31 December 2018 of €8.1m.

As at 31 December 2018 Sentiance had net assets of €4.2m including cash of €3.8m. At 31 December 2018 Sentiance had 37 full time employees and 2 part time employees. Sentiance's subsidiaries are (1) Sentiance UK Limited, (2) Sentiance US Inc., (3) Sentiance Baltics UAB, (4) Sentiance Canada Inc. and (5) Sentiance (Shanghai) Information Technology Co. Ltd.

The 2018 results are unaudited, unconsolidated and historic and the Directors believe do not reflect the progress of Sentiance since 1 January 2019. For Sentiance 2018 was a year of development. The business has progressed with commercialisation throughout 2019 leading to an expected year of rollout in 2020. Sentiance now has 32 clients including a number of global leading technology providers, financial institutions and disruptive insurance and mobility platforms.

Following completion of the Proposals Asimilar will have cash resources to be able to complete its proposed initial subscription for 10,000 new Sentiance shares at a subscription price of €750 per share for an aggregate cash consideration of €7,500,000.

While subscribers to the Placing are legally bound to participate in the Placing on the conditions set out above, there is no guarantee that any definitive agreement in relation to the Proposals will be reached with Sentiance.

Following the surrender of subscription rights by the participants in Tranche 2 of the 8 January 2020 placing (as announced today) and completion of the Placing and after adjusting for estimated costs incurred in connection therewith, the Directors estimate that the net asset value of Asimilar on Admission will be approximately £16.2 million which, while significantly below the Company's current market capitalisation, does not take into account the Board's view of the intrinsic value of the Company's investment in Sentiance.

The Company's current issued share capital comprise 105,361,443 Ordinary Shares.

There are currently warrants in issue over 59,395,833 new Ordinary Shares ("Existing Warrants"), representing approximately 36 per cent of the enlarged issued share capital of the Company (as so enlarged by the exercise of the Existing Warrants). The Existing Warrants may be exercised at prices between 5p and 130p at various dates to 3 December 2022. Full details of the Existing Warrants are set out on the Company's website at http://www.asimilargroup.com/content/investors/shareholder_profile.asp 

As described above the Company will issue warrants over a further 16,000,000 new Ordinary Shares pursuant to the Placing Warrants and the Introducer Warrants. Furthermore, a further 3,500,000 Compensation Warrants will be issued pursuant to the surrender of subscription rights by the participants in Tranche 2 of the 8 January 2020 placing, details of which are set out above.

John Taylor, Chairman of Asimilar said: "We are pleased with the ongoing support we have received from our shareholders and in particular their shared excitement about our proposed investment in Sentiance."

"We believe that Sentiance will emerge as one of the market leaders in the field of artificial intelligence, machine learning and contextual behavioural science and we continue to work diligently with Sentiance and our advisors on preparing our Admission Document."

Further announcements will be made in due course.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

 

John Taylor, Non-Executive Chairman

via Buchanan

 

 

Cairn Financial Advisers LLP

 

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

 

 

Peterhouse Capital Limited

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

Buchanan Communications Limited

 

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEAKDAFFKEEFA
Date   Source Headline
1st Apr 20213:58 pmRNSExercise of Warrants
31st Mar 20216:04 pmRNSExtension of Warrant Exercise Date
30th Mar 20217:00 amRNSAnnual Report and Accounts and Portfolio Update
29th Mar 20215:32 pmRNSExercise of Warrants & Vesting of Warrants
26th Mar 20213:36 pmRNSExercise of Warrants
22nd Mar 20211:17 pmRNSHolding(s) in Company
18th Mar 20217:00 amRNSCompletion of Subscription
9th Mar 20212:06 pmRNSUpdate re MESH
1st Mar 202111:02 amRNSDev Clever Subscription
25th Feb 20217:00 amRNSAssignment of Subscription Rights
17th Feb 20214:29 pmRNSExercise of Warrants
15th Feb 202111:35 amRNSAnnouncement of Agreement by MESH re Sentiance
27th Jan 20217:00 amRNSUpdate re: Dev Clever Subscription Rights
26th Jan 20217:00 amRNSUpdate re subscription in Dev Clever
18th Jan 20219:51 amRNSExercise of Warrants
13th Jan 20218:28 amRNSExercise of Warrants
12th Jan 20214:41 pmRNSSecond Price Monitoring Extn
12th Jan 20214:35 pmRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSFurther Equity Investment in SeeQuestor
21st Dec 20207:30 amRNSStatement re Announcement by Dev Clever
17th Dec 20207:00 amRNSDirector's Disclosure
7th Dec 20207:00 amRNSFurther Investment in Magic Media Works
1st Dec 20207:00 amRNSFurther conditional investment in Dev Clever
30th Nov 20204:08 pmRNSAssignment of Sentiance Loan
24th Nov 20207:00 amRNSDirector's Dealing
9th Nov 20202:49 pmRNSUpdate re Magic Media Works Limited
9th Nov 20207:00 amRNSFurther Investment in SeeQuestor
2nd Nov 20207:00 amRNSUpdate re Dev Clever Subscription Rights
26th Oct 202011:21 amRNSResult of AGM
23rd Oct 20207:00 amRNSExercise of Warrants
20th Oct 20207:00 amRNSAward of Warrants to Director
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSNotice of AGM & Update re Loan to Sentiance
29th Sep 20203:18 pmRNSHolding(s) in Company
23rd Sep 20203:24 pmRNSBoard Changes
16th Sep 202012:57 pmRNSExercise of Warrants
10th Sep 202012:00 pmRNSUpdate re: Dev Clever Holdings plc
8th Sep 20202:39 pmRNSMarket Update
7th Sep 20207:00 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSExercise of Subscription rights
1st Sep 20207:00 amRNSAcquisition of Intrinsic Capital (Jersey) Ltd
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
25th Aug 20207:30 amRNSRestoration - Asimilar Group plc
25th Aug 20207:00 amRNSCompletion of Agreement & Lifting of Suspension
20th Aug 202011:29 amRNSMESH AGM
3rd Aug 20203:12 pmRNSAgreement with MESH Holdings plc
31st Jul 202012:14 pmRNSUpdate re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.